Chemoinformaics analysis of 2-(methoxymethyl)aniline
| Molecular Weight | 137.182 | nRot | 2 |
| Heavy Atom Molecular Weight | 126.094 | nRig | 6 |
| Exact Molecular Weight | 137.084 | nRing | 1 |
| Solubility: LogS | -0.818 | nHRing | 0 |
| Solubility: LogP | 0.982 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 22.5967 |
| nHD | 1 | BPOL | 12.2013 |
| QED | 0.625 |
| Synth | 1.715 |
| Natural Product Likeliness | -0.277 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.956 |
| HIA | 0.003 |
| CACO-2 | -4.403 |
| MDCK | 0.0000781 |
| BBB | 0.347 |
| PPB | 0.215257 |
| VDSS | 1.346 |
| FU | 0.684906 |
| CYP1A2-inh | 0.3 |
| CYP1A2-sub | 0.423 |
| CYP2c19-inh | 0.204 |
| CYP2c19-sub | 0.837 |
| CYP2c9-inh | 0.037 |
| CYP2c9-sub | 0.08 |
| CYP2d6-inh | 0.103 |
| CYP2d6-sub | 0.866 |
| CYP3a4-inh | 0.03 |
| CYP3a4-sub | 0.343 |
| CL | 6.785 |
| T12 | 0.619 |
| hERG | 0.036 |
| Ames | 0.889 |
| ROA | 0.566 |
| SkinSen | 0.863 |
| Carcinogencity | 0.796 |
| EI | 0.99 |
| Respiratory | 0.299 |
| NR-Aromatase | 0.038 |
| Antiviral | No |
| Prediction | 0.908481 |